RxDoctor Payments Data

Teresa Song

New York, NYNPI 1679136790

Payments from drug & device makers

$7,916in general payments, 2019–2025

Across 172 payments — averaging $46.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Solta Medical, A Division Of Bausch Health US, LLC$2K
  • AbbVie$820
  • Almirall LLC$545
  • Dermavant Sciences, Inc.$543
  • Incyte Corporation$469
  • Johnson & Johnson$376
  • plus $3K from 19 others

What the payments were for

  • Speaking & faculty fees$2,47531%
  • Food & beverage$5,44169%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus12$1,743
Clobetasol Propionate48$1,498
Triamcinolone Acetonide67$1,124
Ketoconazole72$1,113
Clindamycin Phosphate17$554
Minoxidil16$205
Mupirocin27$184
Ammonium Lactate11$141
Hydrocortisone20$84

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →